TLPH
Talphera, Inc.
Price Chart
Latest Quote
$1.03
+0.06 (+6.17%)
Current Price
| Previous Close | $0.97 |
| Open | $0.96 |
| Day High | $1.06 |
| Day Low | $0.96 |
| Volume | 143,573 |
Stock Information
| Shares Outstanding | 51.90M |
| Total Debt | $6.50M |
| Cash Equivalents | $21.11M |
| Revenue | $1K |
| Net Income | $-14.25M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $53.46M |
| EPS (TTM) | $-0.28 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $33.20M |
| Sales | $1K |
| Income | $-14.25M |
| Book/sh | $0.34 |
| Cash/sh | $0.41 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 5.24 |
| Current Ratio | 5.30 |
| Debt/Eq | 35.17 |
Returns & Margins
| ROA | -40.19% |
| ROE | -118.40% |
| Operating Margin | -1451600.00% |
Ownership
| Insider Ownership | 21.38% |
| Institutional Ownership | 34.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.81 |
| P/S | 53456.64 |
| P/B | 2.99 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $3.17 |
Technical Indicators
| SMA20 | $0.84 |
| SMA50 | $0.84 |
| SMA200 | $0.98 |
| RSI | 74.42 |
| ATR | 0.0686 |
| Shares Float | 26.75M |
| Short Float | 2.16% |
| Short Ratio | 6.15 |
| Rel Volume | 0.92 |
Performance History
| Week | +24.10% |
| Month | +24.10% |
| Quarter | +27.16% |
| 6 Months | -14.17% |
| YTD | -11.21% |
| Year | +114.58% |
| 3 Years | -16.26% |
| 5 Years | -96.66% |
| 10 Years | -98.21% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.03 | 143,573 |
| 2026-06-17 | $0.97 | 378,800 |
| 2026-06-16 | $0.92 | 175,000 |
| 2026-06-15 | $0.89 | 140,700 |
| 2026-06-12 | $0.87 | 233,800 |
| 2026-06-11 | $0.83 | 156,100 |
| 2026-06-10 | $0.81 | 73,800 |
| 2026-06-09 | $0.82 | 171,000 |
| 2026-06-08 | $0.85 | 406,500 |
| 2026-06-05 | $0.78 | 163,200 |
| 2026-06-04 | $0.80 | 126,400 |
| 2026-06-03 | $0.77 | 140,600 |
| 2026-06-02 | $0.78 | 130,000 |
| 2026-06-01 | $0.79 | 97,100 |
| 2026-05-29 | $0.82 | 186,300 |
| 2026-05-28 | $0.82 | 92,100 |
| 2026-05-27 | $0.82 | 77,900 |
| 2026-05-26 | $0.80 | 109,900 |
| 2026-05-22 | $0.82 | 43,900 |
| 2026-05-21 | $0.82 | 58,000 |
| 2026-05-20 | $0.82 | 208,400 |
| 2026-05-19 | $0.83 | 158,200 |
| 2026-05-18 | $0.80 | 270,100 |
About Talphera, Inc.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
đ° Latest News
Talphera, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-14T12:30:00Z
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...
GuruFocus.com âĸ 2026-05-14T05:02:31ZTalphera Q1 2026 Earnings Call Transcript
Benzinga âĸ 2026-05-13T21:40:18Z
Talphera (TLPH) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-13T21:37:09Z
Talphera: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-23T12:44:39ZThis Talphera Insider Increased Their Holding By 138% Last Year
Simply Wall St. âĸ 2025-12-07T12:50:45Z
Talphera (TLPH) Q3 2025 Earnings Call Transcript
Motley Fool âĸ 2025-11-13T17:15:40Z
Talphera Inc (TLPH) Q3 2025 Earnings Call Highlights: Strategic Investments and Regulatory ...
GuruFocus.com âĸ 2025-11-13T05:00:49Z
Talphera: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-12T21:23:37ZBC-Most Active Stocks
Associated Press Finance âĸ 2025-09-08T14:30:19Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $28,000 | $0 | $651,000 | $0 |
| Operating Revenue | $28,000 | $0 | $651,000 | $0 |
| Reconciled Cost Of Revenue | - | - | - | $2,591,000 |
| Cost Of Revenue | - | - | - | $2,591,000 |
| Expenses | ||||
| Interest Expense | $0 | $394,000 | $134,000 | $1,116,000 |
| Total Expenses | $13,512,000 | $15,252,000 | $17,540,000 | $20,352,000 |
| Other Income Expense | $-1,315,000 | $1,963,000 | $5,320,000 | $79,104,000 |
| Net Non Operating Interest Income Expense | $436,000 | $285,000 | $1,282,000 | $386,000 |
| Interest Expense Non Operating | $0 | $394,000 | $134,000 | $1,116,000 |
| Operating Expense | $13,512,000 | $15,252,000 | $17,540,000 | $20,352,000 |
| Other Non Operating Income Expenses | - | - | - | $84,052,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-14,363,000 | $-13,004,000 | $-10,287,000 | $59,125,000 |
| Net Interest Income | $436,000 | $285,000 | $1,282,000 | $386,000 |
| Interest Income | $436,000 | $679,000 | $1,416,000 | $1,502,000 |
| Normalized Income | $-13,048,000 | $-14,967,000 | $-15,607,000 | $-19,961,611 |
| Net Income From Continuing And Discontinued Operation | $-14,290,000 | $-13,004,000 | $-18,397,000 | $47,755,000 |
| Total Operating Income As Reported | $-13,484,000 | $-15,252,000 | $-16,889,000 | $-25,300,000 |
| Net Income Common Stockholders | $-14,290,000 | $-13,004,000 | $-18,397,000 | $42,329,000 |
| Net Income | $-14,290,000 | $-13,004,000 | $-18,397,000 | $47,755,000 |
| Net Income Including Noncontrolling Interests | $-14,290,000 | $-13,004,000 | $-18,397,000 | $47,755,000 |
| Net Income Discontinuous Operations | $73,000 | $0 | $-8,110,000 | $-11,370,000 |
| Net Income Continuous Operations | $-14,363,000 | $-13,004,000 | $-10,287,000 | $59,125,000 |
| Pretax Income | $-14,363,000 | $-13,004,000 | $-10,287,000 | $59,138,000 |
| Interest Income Non Operating | $436,000 | $679,000 | $1,416,000 | $1,502,000 |
| Operating Income | $-13,484,000 | $-15,252,000 | $-16,889,000 | $-20,352,000 |
| Special Income Charges | - | - | $0 | $79,104,000 |
| Gross Profit | - | - | - | $-820,000 |
| Per Share | ||||
| Diluted EPS | $-0.34 | $-0.50 | $-1.29 | $5.72 |
| Basic EPS | $-0.34 | $-0.50 | $-1.29 | $5.73 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $17,389 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-13,048,000 | $-14,573,000 | $-15,162,000 | $-17,203,000 |
| Total Unusual Items | $-1,315,000 | $1,963,000 | $5,320,000 | $79,104,000 |
| Total Unusual Items Excluding Goodwill | $-1,315,000 | $1,963,000 | $5,320,000 | $79,104,000 |
| EBITDA (Bullshit earnings) | $-14,363,000 | $-12,610,000 | $-9,842,000 | $61,901,000 |
| EBIT | $-14,363,000 | $-12,610,000 | $-10,153,000 | $60,254,000 |
| Diluted Average Shares | $42,411,000 | $25,846,000 | $14,263,744 | $7,406,986 |
| Basic Average Shares | $42,411,000 | $25,846,000 | $14,263,744 | $7,385,348 |
| Diluted NI Availto Com Stockholders | $-14,290,000 | $-13,004,000 | $-18,397,000 | $42,342,000 |
| Gain On Sale Of Security | $-1,315,000 | $1,963,000 | $5,320,000 | - |
| Research And Development | $6,033,000 | $6,718,000 | $5,546,000 | $3,341,000 |
| Selling General And Administration | $7,479,000 | $8,534,000 | $11,994,000 | $17,011,000 |
| Reconciled Depreciation | - | $0 | $311,000 | $1,647,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $5,240,000 |
| Tax Provision | - | - | $0 | $13,000 |
| Impairment Of Capital Assets | - | - | $0 | $4,948,000 |
| Preferred Stock Dividends | - | - | - | $186,000 |
| Other Special Charges | - | - | - | $-84,052,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $8,216,000 | $-818,000 | $5,286,000 | $12,995,000 |
| Total Assets | $29,719,000 | $18,236,000 | $20,395,000 | $47,487,000 |
| Total Non Current Assets | $8,819,000 | $8,819,000 | $8,819,000 | $22,921,000 |
| Goodwill And Other Intangible Assets | $8,819,000 | $8,819,000 | $8,819,000 | $8,819,000 |
| Other Intangible Assets | $8,819,000 | $8,819,000 | $8,819,000 | $8,819,000 |
| Current Assets | $20,900,000 | $9,417,000 | $11,576,000 | $24,566,000 |
| Other Current Assets | $519,000 | $554,000 | $2,195,000 | $1,865,000 |
| Cash Cash Equivalents And Short Term Investments | $20,381,000 | $8,863,000 | $9,381,000 | $15,770,000 |
| Cash And Cash Equivalents | $5,894,000 | $8,863,000 | $5,721,000 | $15,275,000 |
| Cash Equivalents | $5,480,000 | $8,499,000 | $4,379,000 | - |
| Cash Financial | $414,000 | $364,000 | $1,342,000 | - |
| Other Non Current Assets | - | - | $20,000 | $14,102,000 |
| Assets Held For Sale Current | - | - | $0 | $1,931,000 |
| Restricted Cash | - | - | $0 | $5,000,000 |
| Inventory | - | - | - | $1,178,000 |
| Receivables | - | - | - | $309,000 |
| Accounts Receivable | - | - | - | $309,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | - | - | - | $5,363,000 |
| Long Term Debt And Capital Lease Obligation | - | - | - | $2,959,000 |
| Current Debt And Capital Lease Obligation | - | - | - | $5,363,000 |
| Current Debt | - | - | - | $5,363,000 |
| Other Current Borrowings | - | - | - | $5,763,000 |
| Net Debt | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,684,000 | $10,235,000 | $6,290,000 | $25,673,000 |
| Total Non Current Liabilities Net Minority Interest | $8,875,000 | $7,588,000 | $1,778,000 | $11,903,000 |
| Other Non Current Liabilities | $6,499,000 | $6,527,000 | - | $810,000 |
| Derivative Product Liabilities | $2,376,000 | $1,061,000 | $1,778,000 | $7,098,000 |
| Current Liabilities | $3,809,000 | $2,647,000 | $4,512,000 | $13,770,000 |
| Other Current Liabilities | $650,000 | $723,000 | $731,000 | $4,620,000 |
| Payables And Accrued Expenses | $1,767,000 | $1,044,000 | $1,776,000 | $2,055,000 |
| Payables | $544,000 | $670,000 | $1,336,000 | $1,256,000 |
| Accounts Payable | $544,000 | $670,000 | $1,336,000 | $1,256,000 |
| Liabilities Heldfor Sale Non Current | - | - | $0 | $3,995,000 |
| Non Current Deferred Liabilities | - | - | - | $1,036,000 |
| Current Deferred Liabilities | - | - | - | $115,000 |
| Current Notes Payable | - | - | - | $5,763,000 |
| Equity | ||||
| Common Stock Equity | $17,035,000 | $8,001,000 | $14,105,000 | $21,814,000 |
| Total Equity Gross Minority Interest | $17,035,000 | $8,001,000 | $14,105,000 | $21,814,000 |
| Stockholders Equity | $17,035,000 | $8,001,000 | $14,105,000 | $21,814,000 |
| Retained Earnings | $-471,520,000 | $-457,230,000 | $-444,226,000 | $-425,829,000 |
| Other | ||||
| Ordinary Shares Number | $49,328,097 | $17,029,469 | $16,952,519 | $8,243,680 |
| Share Issued | $49,328,097 | $17,029,469 | $16,952,519 | $8,243,680 |
| Tangible Book Value | $8,216,000 | $-818,000 | $5,286,000 | $12,995,000 |
| Invested Capital | $17,035,000 | $8,001,000 | $14,105,000 | $27,177,000 |
| Working Capital | $17,091,000 | $6,770,000 | $7,064,000 | $10,796,000 |
| Total Capitalization | $17,035,000 | $8,001,000 | $14,105,000 | $21,814,000 |
| Additional Paid In Capital | $488,506,000 | $465,214,000 | $458,314,000 | $447,635,000 |
| Capital Stock | $49,000 | $17,000 | $17,000 | $8,000 |
| Common Stock | $49,000 | $17,000 | $17,000 | $8,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,392,000 | $880,000 | $2,005,000 | $1,732,000 |
| Current Accrued Expenses | $1,223,000 | $374,000 | $440,000 | $799,000 |
| Other Short Term Investments | $14,487,000 | $0 | $3,660,000 | $495,000 |
| Capital Lease Obligations | - | - | - | $4,660,000 |
| Non Current Deferred Revenue | - | - | - | $1,036,000 |
| Long Term Capital Lease Obligation | - | - | - | $2,959,000 |
| Current Deferred Revenue | - | - | - | $115,000 |
| Current Capital Lease Obligation | - | - | - | $1,701,000 |
| Net PPE | - | - | - | $13,856,000 |
| Accumulated Depreciation | - | - | - | $-11,593,000 |
| Gross PPE | - | - | - | $25,449,000 |
| Leases | - | - | - | $5,838,000 |
| Construction In Progress | - | - | - | $8,979,000 |
| Other Properties | - | - | - | $8,817,000 |
| Machinery Furniture Equipment | - | - | - | $1,815,000 |
| Properties | - | - | - | $0 |
| Finished Goods | - | - | - | $44,000 |
| Work In Process | - | - | - | $338,000 |
| Raw Materials | - | - | - | $796,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-11,364,000 | $-12,683,000 | $-17,592,000 | $-28,695,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-11,364,000 | $-12,683,000 | $-17,492,000 | $-28,331,000 |
| Cash Flow From Continuing Operating Activities | $-11,364,000 | $-12,683,000 | $-17,492,000 | $-28,331,000 |
| Operating Gains Losses | $1,315,000 | $-717,000 | $-5,720,000 | $775,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-14,345,000 | $3,781,000 | $-528,000 | $36,450,000 |
| Cash Flow From Continuing Investing Activities | $-14,345,000 | $3,781,000 | $-528,000 | $36,450,000 |
| Capital Expenditure | - | - | $-100,000 | $-364,000 |
| Net Other Investing Changes | - | - | $2,723,000 | $-1,687,000 |
| Financing Activities | ||||
| Financing Cash Flow | $22,740,000 | $12,044,000 | $3,466,000 | $-507,000 |
| Cash Flow From Continuing Financing Activities | $22,740,000 | $12,044,000 | $3,466,000 | $-507,000 |
| Issuance Of Capital Stock | - | $0 | $8,856,000 | $8,225,000 |
| Net Other Financing Charges | - | $6,133,000 | $-22,000 | $-58,000 |
| Net Common Stock Issuance | - | $0 | $8,856,000 | $7,986,000 |
| Common Stock Issuance | - | $0 | $8,856,000 | $7,986,000 |
| Repurchase Of Capital Stock | - | - | $0 | $-315,000 |
| Net Preferred Stock Issuance | - | - | $0 | $-76,000 |
| Preferred Stock Issuance | - | - | $0 | $239,000 |
| Other | ||||
| End Cash Position | $5,894,000 | $8,863,000 | $5,721,000 | $20,275,000 |
| Beginning Cash Position | $8,863,000 | $5,721,000 | $20,275,000 | $12,663,000 |
| Changes In Cash | $-2,969,000 | $3,142,000 | $-14,554,000 | $7,612,000 |
| Proceeds From Stock Option Exercised | $22,740,000 | $5,911,000 | $26,000 | $74,000 |
| Net Investment Purchase And Sale | $-14,345,000 | $3,781,000 | $-3,151,000 | $38,501,000 |
| Sale Of Investment | $3,470,000 | $8,760,000 | $500,000 | $46,362,000 |
| Purchase Of Investment | $-17,815,000 | $-4,979,000 | $-3,651,000 | $-7,861,000 |
| Change In Working Capital | $1,082,000 | $-224,000 | $-1,541,000 | $-1,390,000 |
| Change In Payables And Accrued Expense | $1,047,000 | $-1,865,000 | $-1,707,000 | $-1,062,000 |
| Change In Accrued Expense | $1,255,000 | $-1,194,000 | $-1,132,000 | $-1,613,000 |
| Change In Payable | $-208,000 | $-671,000 | $-575,000 | $551,000 |
| Change In Account Payable | $-208,000 | $-671,000 | $-575,000 | $551,000 |
| Change In Prepaid Assets | $35,000 | $1,641,000 | $281,000 | $299,000 |
| Other Non Cash Items | $-28,000 | $394,000 | $-1,768,000 | $-84,955,000 |
| Stock Based Compensation | $699,000 | $989,000 | $1,729,000 | $2,889,000 |
| Amortization Of Securities | $-142,000 | $-121,000 | $-24,000 | - |
| Gain Loss On Investment Securities | $1,315,000 | $-717,000 | $-5,320,000 | $775,000 |
| Net Income From Continuing Operations | $-14,290,000 | $-13,004,000 | $-18,397,000 | $47,755,000 |
| Repayment Of Debt | - | $0 | $-5,416,000 | $-8,433,000 |
| Interest Paid Supplemental Data | - | $0 | $119,000 | $837,000 |
| Net Issuance Payments Of Debt | - | $0 | $-5,416,000 | $-8,433,000 |
| Net Long Term Debt Issuance | - | $0 | $-5,416,000 | $-8,433,000 |
| Long Term Debt Payments | - | $0 | $-5,416,000 | $-8,433,000 |
| Net PPE Purchase And Sale | - | $0 | $-100,000 | $-364,000 |
| Purchase Of PPE | - | $0 | $-100,000 | $-364,000 |
| Change In Other Current Liabilities | - | $0 | $-147,000 | $-285,000 |
| Change In Inventory | - | $0 | $61,000 | $-107,000 |
| Asset Impairment Charge | - | $0 | $7,918,000 | $4,948,000 |
| Depreciation Amortization Depletion | - | $0 | $311,000 | $1,647,000 |
| Depreciation And Amortization | - | $0 | $311,000 | $1,647,000 |
| Preferred Stock Payments | - | - | $0 | $-315,000 |
| Change In Other Working Capital | - | - | $-29,000 | $-86,000 |
| Change In Other Current Assets | - | - | $226,000 | $0 |
| Change In Receivables | - | - | $-189,000 | $-149,000 |
| Changes In Account Receivables | - | - | $-189,000 | $-149,000 |
Fetched: 2026-06-17